Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Connection

Laura Dunn to Schizophrenia

This is a "connection" page, showing publications Laura Dunn has written about Schizophrenia.

 
Connection Strength
 
 
 
2.084
 
  1. Dunn LB, Kim DS, Fellows IE, Palmer BW. Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research. Schizophr Bull. 2009 Jul; 35(4):730-7.
    View in: PubMed
    Score: 0.268
  2. Dunn LB. Ethical issues in schizophrenia: considerations for treatment and research. Psychopharmacol Bull. 2007; 40(4):145-55.
    View in: PubMed
    Score: 0.248
  3. Roberts LW, Warner TD, Hammond KG, Dunn LB. Assessments by patients with schizophrenia and psychiatrists of relative risk of research procedures. Psychiatr Serv. 2006 Nov; 57(11):1629-35.
    View in: PubMed
    Score: 0.245
  4. Dunn LB, Palmer BW, Appelbaum PS, Saks ER, Aarons GA, Jeste DV. Prevalence and correlates of adequate performance on a measure of abilities related to decisional capacity: differences among three standards for the MacCAT-CR in patients with schizophrenia. Schizophr Res. 2007 Jan; 89(1-3):110-8.
    View in: PubMed
    Score: 0.243
  5. Dunn LB, Palmer BW, Keehan M, Jeste DV, Appelbaum PS. Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument. Am J Psychiatry. 2006 Mar; 163(3):500-6.
    View in: PubMed
    Score: 0.234
  6. Dunn LB. Capacity to consent to research in schizophrenia: the expanding evidence base. Behav Sci Law. 2006; 24(4):431-45.
    View in: PubMed
    Score: 0.231
  7. Dunn LB, Palmer BW, Keehan M. Understanding of placebo controls among older people with schizophrenia. Schizophr Bull. 2006 Jan; 32(1):137-46.
    View in: PubMed
    Score: 0.227
  8. Jeste DV, Palmer BW, Golshan S, Eyler LT, Dunn LB, Meeks T, Glorioso D, Fellows I, Kraemer H, Appelbaum PS. Multimedia consent for research in people with schizophrenia and normal subjects: a randomized controlled trial. Schizophr Bull. 2009 Jul; 35(4):719-29.
    View in: PubMed
    Score: 0.067
  9. Roberts LW, Dunn LB, Green Hammond KA, Warner TD. Do research procedures pose relatively greater risk for healthy persons than for persons with schizophrenia? Schizophr Bull. 2006 Jan; 32(1):153-8.
    View in: PubMed
    Score: 0.057
  10. Palmer BW, Dunn LB, Appelbaum PS, Jeste DV. Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia. Arch Gen Psychiatry. 2004 Mar; 61(3):230-6.
    View in: PubMed
    Score: 0.051
  11. Dunn LB, Jeste DV. Problem areas in the understanding of informed consent for research: study of middle-aged and older patients with psychotic disorders. Psychopharmacology (Berl). 2003 Dec; 171(1):81-5.
    View in: PubMed
    Score: 0.048
  12. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry. 2002 Oct; 63(10):892-909.
    View in: PubMed
    Score: 0.046
  13. Dolder CR, Lacro JP, Dunn LB, Jeste DV. Antipsychotic medication adherence: is there a difference between typical and atypical agents? Am J Psychiatry. 2002 Jan; 159(1):103-8.
    View in: PubMed
    Score: 0.044
  14. Rosenheck R, Dunn L, Peszke M, Cramer J, Xu W, Thomas J, Charney D. Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Am J Psychiatry. 1999 Jan; 156(1):88-93.
    View in: PubMed
    Score: 0.036
  15. Jeste DV, Palmer BW, Appelbaum PS, Golshan S, Glorioso D, Dunn LB, Kim K, Meeks T, Kraemer HC. A new brief instrument for assessing decisional capacity for clinical research. Arch Gen Psychiatry. 2007 Aug; 64(8):966-74.
    View in: PubMed
    Score: 0.016
  16. Palmer BW, Dunn LB, Appelbaum PS, Mudaliar S, Thal L, Henry R, Golshan S, Jeste DV. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument. Arch Gen Psychiatry. 2005 Jul; 62(7):726-33.
    View in: PubMed
    Score: 0.014
  17. Jeste DV, Dunn LB, Palmer BW, Saks E, Halpain M, Cook A, Appelbaum P, Schneiderman L. A collaborative model for research on decisional capacity and informed consent in older patients with schizophrenia: bioethics unit of a geriatric psychiatry intervention research center. Psychopharmacology (Berl). 2003 Dec; 171(1):68-74.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.